Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1980 Sep;42(3):408-15.
doi: 10.1038/bjc.1980.252.

Mechanism by which antibodies to non-AgB antigens mediate rejection of rat leukaemia cells

Free PMC article

Mechanism by which antibodies to non-AgB antigens mediate rejection of rat leukaemia cells

S Denham et al. Br J Cancer. 1980 Sep.
Free PMC article

Abstract

The August and Hooded rat strains are compatible at the major histocompatibility locus (both are AgB5 or Rtlc). Antisera against the minor histocompatibility antigens of Hooded rats were raised by immunizing August rats with grafts of tumours or normal tissue. Such antisera, if transferred to normal unimmunized August rats, cause them to reject i.v. administered Hooded rat leukemia (HRL) cells within a few hours, and X-irradiated August rats, for whom a graft of HRL is lethal, can survive indefinitely if pretreated with the antiserum. The distribution of 125I-labelled HRL cells in the tissues of August rats was followed at times after their injection, and it was found that, in the presence of antiserum, i.v. administered leukaemic cells are rapidly destroyed in the liver and spleen. The active component of the antiserum is IgG antibody, and its action is independent of the lytic elements of complement. Antibody-mediated splenic and hepatic clearance of the leukaemia cells is unaffected by total-body X-irradiation but reduced by treating the rats with colloidal carbon. The data are consistent with the hypothesis that the rejection of HRL across the histocompatibility barrier studied is, in the presence of antibody, effected by immunophagocytosis.

PubMed Disclaimer

Similar articles

Cited by

  • Macrophages and antitumor reactions.
    Den Otter W, Dullens HF, De Weger RA. Den Otter W, et al. Cancer Immunol Immunother. 1983;16(2):67-71. doi: 10.1007/BF00199233. Cancer Immunol Immunother. 1983. PMID: 6362848 Free PMC article. Review. No abstract available.

References

    1. Adv Cancer Res. 1970;13:1-37 - PubMed
    1. Proc Natl Acad Sci U S A. 1974 Jan;71(1):163-6 - PubMed
    1. Immunology. 1974 Nov;27(5):903-22 - PubMed
    1. Br J Cancer. 1976 Feb;33(2):172-80 - PubMed
    1. Br J Cancer. 1976 May;33(5):512-20 - PubMed

Publication types